Human challenge trials have been used to test other vaccines but there were rescue medicines to cure those who got sick. There is no cure for COVID-19.
Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher
The vaccine has been licensed to AstraZeneca and is in its Phase III of its human trials in the UK.
China allows limited use of COVID-19 vaccine CanSino for their military after clinical trials shows its effectiveness
The vaccine has been approved for a period of one year after clinical trials proved it was safe and showed some efficacy.
First COVID-19 vaccine to enter human trials is safe, well-tolerated and able to generate immune response against virus
The trial was carried out in 108 healthy adults with the vaccine demonstrating promising results after 28 days.
The preliminary findings, in the first eight people, must be repeated in thousands of people, to find out if the vaccine works in the real world.
Coronavirus India Roundup, May 5: Highest increase in cases and deaths in the last 24 hours, death toll reaches 1,583
India observed the highest increase in the number of confirmed cases and deaths in the last 24 hours, with 3,900 new cases and 195 patients passing away.
Gilead rubbishes claim that antiviral drug, Remdesivir, failed to help Coronavirus patients in Chinese trial
Doctors suggest antiviral drugs would be most effective when administered as early as possible as it helps keep the virus from replicating in the blood.
Coronavirus Outbreak: Leaked results of a clinical trial hints Gliead's Remdesivir could be possible COVID-19 cure
During the trial, 113 patients were treated with the drug, most were discharged from the hospital in under a week, and only two died.
They are waiting on the final approvals but are recruiting volunteers, taking blood tests, and explaining the process while checking their health status.
Initial study of remdesivir, an antiviral drug, shows that two-thirds of severe COVID-19 patients got better
For now, Remdesivir is available for compassionate use, meaning that doctors can request the drug if a patient is in a dire situation with no alternatives.
Potential COVID-19 vaccines: From a self-limiting virus to a self-assembling vaccine, scientists are pulling out all the stops
There is currently no authorized treatment for the infection, though various governments have green-lighted emergency treatments with little evidence.
Clinical trials of influenza drug, Favipiravir, shows positive effect in treatment of coronavirus in China
Results showed patients receiving Favipiravir turned negative for the virus in a shorter time compared with those in the control group
Trials are being done using arthritis, HIV and a combination of other existing drugs to treat the novel coronavirus.
Several antiviral drugs to treat the coronavirus outbreak under clinical trials, shown good efficacy: Chinese official
Hospitals are using plasma from recovered patients, that is rich in protective antibodies, to treat severely affected patients.
107th Indian Science Congress in Bangalore: Indian-American cardiologist to present new way to test effectiveness of yoga
He will introduce the "new protocol" at the 107th India Science Congress that is taking place in Bangalore.
It's also looking into human enhancement where human brains will be able to communicate with computers.
Glenmark launched Remogliflozin, indicated in the treatment of Type 2 Diabetes Mellitus in adults under the brand names 'Remo' and 'Remozen'.
Currently prescribed drugs to Alzheimer's patients offer symptomatic relief, but do not slow, stop or reverse the damage done.
Indian government is working with stakeholders to devise new rules for clinical trials that are expected to bring new projects to India.
Indian Council of Medical Research (ICMR), along with other global health bodies, have decided to adopt UN health agency's recommendations on clinical trials.